510(k) K881816
K881816 is an FDA 510(k) premarket notification submitted by Roche Diagnostic Systems, Inc. for the device "ABUSCREEN(R) ONTRAK(TM) FOR BARBITURATES". The FDA issued a decision of Substantially Equivalent on July 28, 1988. The device falls under product code DKN (Radioimmunoassay, Barbiturate), a Class II device regulated under 21 CFR 862.3150. Roche Diagnostic Systems, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 28, 1988
- Date Received
- April 28, 1988
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Radioimmunoassay, Barbiturate
- Device Class
- Class II
- Regulation Number
- 862.3150
- Review Panel
- TX
- Submission Type